Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The EURECCA project: Data items scored by European colorectal cancer audit registries.
van Gijn W, van den Broek CB, Mroczkowski P, Dziki A, Romano G, Pavalkis D, Wouters MW, Møller B, Wibe A, Påhlman L, Harling H, Smith JJ, Penninckx F, Ortiz H, Valentini V, van de Velde CJ.
Eur J Surg Oncol. 2012 Jun;38(6):467-71. Epub 2012 Jan 27.
Related citations
Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study.
Mantke R, Schmidt U, Wolff S, Kube R, Lippert H.
Eur J Surg Oncol. 2012 Mar;38(3):259-65. Epub 2011 Dec 29.
Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
Zhou YJ, Xie YT, Gu J, Yan L, Guan GX, Liu X.
Eur J Surg Oncol. 2011 Dec;37(12):1078-84. Epub 2011 Sep 22.
Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review.
Spelt L, Andersson B, Nilsson J, Andersson R.
Eur J Surg Oncol. 2012 Jan;38(1):16-24. Epub 2011 Nov 12. Review.
The number of high-risk factors is related to outcome in stage II colonic cancer patients.
Koebrugge B, Vogelaar FJ, Lips DJ, Pruijt JF, van der Linden JC, Ernst MF, Bosscha K.
Eur J Surg Oncol. 2011 Nov;37(11):964-70. Epub 2011 Sep 17.
Variation in case-mix between hospitals treating colorectal cancer patients in the Netherlands.
Kolfschoten NE, Marang van de Mheen PJ, Gooiker GA, Eddes EH, Kievit J, Tollenaar RA, Wouters MW; Dutch Surgical Colorectal Audit group.
Eur J Surg Oncol. 2011 Nov;37(11):956-63. Epub 2011 Sep 22.
Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis.
Sugarbaker PH, Van der Speeten K, Anthony Stuart O, Chang D.
Eur J Surg Oncol. 2011 Aug;37(8):719-26. Epub 2011 May 31.
The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival.
van den Broek CB, Dekker JW, Bastiaannet E, Krijnen P, de Craen AJ, Tollenaar RA, van de Velde CJ, Liefers GJ.
Eur J Surg Oncol. 2011 Oct;37(10):904-12. Epub 2011 Jul 23.
Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.
Hompes D, Ruers T.
Eur J Surg Oncol. 2011 Sep;37(9):737-46. Epub 2011 Jul 20. Review.
Type IV collagen as a tumour marker for colorectal liver metastases.
Nyström H, Naredi P, Hafström L, Sund M.
Eur J Surg Oncol. 2011 Jul;37(7):611-7. Epub 2011 May 28.
A phase I/II study of neoadjuvant chemotherapy with Pemetrexed (Alimta) in rectal cancer.
Derwinger K, Kodeda K, Swartling T, Kälebo P, Carlsson G, Gustavsson B.
Eur J Surg Oncol. 2011 Jul;37(7):583-8. Epub 2011 May 6.
Validity and reliability of the MSKCC Bowel Function instrument in a sample of Italian rectal cancer patients.
Zotti P, Del Bianco P, Serpentini S, Trevisanut P, Barba MC, Valentini V, De Paoli A, Pucciarelli S.
Eur J Surg Oncol. 2011 Jul;37(7):589-96. Epub 2011 May 5.
Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor.
Zabaleta J, Aguinagalde B, Fuentes MG, Bazterargui N, Izquierdo JM, Hernández CJ, Enriquez-Navascués JM, Emparanza JI.
Eur J Surg Oncol. 2011 Sep;37(9):786-90. Epub 2011 Jul 2.
MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.
Nugent M, Miller N, Kerin MJ.
Eur J Surg Oncol. 2011 Aug;37(8):649-54. Epub 2011 May 31. Review.
MicroRNA-21 and PDCD4 expression in colorectal cancer.
Chang KH, Miller N, Kheirelseid EA, Ingoldsby H, Hennessy E, Curran CE, Curran S, Smith MJ, Regan M, McAnena OJ, Kerin MJ.
Eur J Surg Oncol. 2011 Jul;37(7):597-603. Epub 2011 May 4.
Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action.
Manchon-Walsh P, Borras JM, Espinas JA, Aliste L; Catalonian Rectal Cancer Group.
Eur J Surg Oncol. 2011 Apr;37(4):325-33. Epub 2011 Feb 5. Erratum in: Eur J Surg Oncol. 2011 Sep;37(9):828.
R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I.
Eur J Surg Oncol. 2011 Apr;37(4):336-43. Epub 2011 Jan 31.
Natural orifice total mesorectal excision using transanal port and laparoscopic assistance.
Tuech JJ, Bridoux V, Kianifard B, Schwarz L, Tsilividis B, Huet E, Michot F.
Eur J Surg Oncol. 2011 Apr;37(4):334-5. Epub 2011 Jan 23.
Tumour VEGF/non tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients.
Morales-Gutiérrez C, Abad-Barahona A, Moreno-González E, Enríquez de Salamanca R, Vegh I.
Eur J Surg Oncol. 2011 Jun;37(6):526-31. Epub 2011 Mar 5.
Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin α(v)β(3) expression in a syngeneic rat model.
Hutteman M, Mieog JS, van der Vorst JR, Dijkstra J, Kuppen PJ, van der Laan AM, Tanke HJ, Kaijzel EL, Que I, van de Velde CJ, Löwik CW, Vahrmeijer AL.
Eur J Surg Oncol. 2011 Mar;37(3):252-7. Epub 2011 Jan 6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on